Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,718 | 352 | 95.9% |
| Education | $288.98 | 3 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,500 | 109 | $0 (2024) |
| Janssen Biotech, Inc. | $963.11 | 44 | $0 (2024) |
| Lilly USA, LLC | $773.69 | 38 | $0 (2024) |
| UCB, Inc. | $473.68 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $422.03 | 48 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $415.86 | 22 | $0 (2024) |
| LEO Pharma Inc. | $264.00 | 12 | $0 (2024) |
| GENZYME CORPORATION | $171.92 | 8 | $0 (2024) |
| Amgen Inc. | $157.22 | 8 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $145.82 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,292 | 119 | ABBVIE INC. ($529.49) |
| 2023 | $2,095 | 98 | ABBVIE INC. ($686.97) |
| 2022 | $1,417 | 83 | ABBVIE INC. ($615.39) |
| 2021 | $1,202 | 55 | AbbVie Inc. ($668.13) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: Immunology | ||||||
| 11/23/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Immunology | ||||||
| 11/23/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $30.48 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Immunology | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.63 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,577 | 2,604 | $327,130 | $85,018 |
| 2022 | 13 | 1,543 | 2,643 | $318,206 | $81,321 |
| 2021 | 14 | 1,459 | 2,313 | $299,252 | $83,152 |
| 2020 | 10 | 819 | 1,640 | $196,387 | $42,715 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 447 | 516 | $95,130 | $24,807 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 141 | $36,880 | $10,498 | 28.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 273 | 304 | $49,683 | $10,075 | 20.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 130 | 144 | $33,670 | $9,474 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 145 | 145 | $32,814 | $8,416 | 25.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 100 | 110 | $23,566 | $6,055 | 25.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 211 | 1,085 | $15,863 | $4,483 | 28.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 27 | 30 | $10,565 | $3,174 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $10,470 | $2,839 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 70 | 71 | $8,074 | $2,457 | 30.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $6,816 | $2,296 | 33.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 16 | $3,600 | $443.48 | 12.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 377 | 419 | $77,400 | $21,074 | 27.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 268 | 290 | $47,395 | $9,606 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 179 | 179 | $40,508 | $9,507 | 23.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 122 | 131 | $30,630 | $8,090 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 104 | $27,202 | $7,634 | 28.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 106 | 109 | $23,352 | $6,328 | 27.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 47 | 54 | $19,016 | $6,011 | 31.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 213 | 1,195 | $17,471 | $5,085 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $13,510 | $3,179 | 23.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 13 | 16 | $5,642 | $1,600 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 51 | $5,800 | $1,360 | 23.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 20 | 28 | $6,300 | $956.78 | 15.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 27 | 27 | $3,980 | $890.24 | 22.4% |
About Angela Sankaran, ARNP
Angela Sankaran, ARNP is a Family healthcare provider based in Spokane Valley, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1891064895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angela Sankaran, ARNP has received a total of $7,007 in payments from pharmaceutical and medical device companies, with $2,292 received in 2024. These payments were reported across 355 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($6,718).
As a Medicare-enrolled provider, Sankaran has provided services to 5,398 Medicare beneficiaries, totaling 9,200 services with total Medicare billing of $292,206. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Spokane Valley, WA
- Active Since 12/20/2011
- Last Updated 10/28/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1891064895
Products in Payments
- SKYRIZI (Biological) $1,704
- RINVOQ (Biological) $657.14
- TREMFYA (Drug) $583.33
- TALTZ (Drug) $544.78
- Sotyktu (Drug) $415.86
- REMICADE (Biological) $379.78
- Cimzia (Drug) $281.67
- ADBRY (Biological) $264.00
- COSENTYX (Drug) $227.48
- DUPIXENT (Biological) $207.49
- Otezla (Drug) $157.22
- COSENTYX (Biological) $152.76
- Bimzelx (Biological) $150.31
- OLUMIANT (Drug) $146.93
- SILIQ (Drug) $133.53
- OPZELURA (Drug) $121.12
- HUMIRA (Biological) $114.29
- Winlevi (Drug) $83.87
- EBGLYSS (Drug) $81.98
- LIBTAYO (Biological) $73.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Spokane Valley
Brittanee Worthy, Arnp, ARNP
Family — Payments: $11,326
Carolyn Campa, Arnp, ARNP
Family — Payments: $6,289
Udoka Eti, Np, NP
Family — Payments: $3,688
Nicole Robinson, Msn Aprn Fnp-C, MSN APRN FNP-C
Family — Payments: $1,973
Mrs. Jaime Crocker, Np, NP
Family — Payments: $1,504
Mrs. Lindsey Fails, Fnp, FNP
Family — Payments: $1,183